ImmunOs Therapeutics Appoints Steve Coats, PhD, as Chief Development Officer
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Stay updated with breaking news from Pfizer Ventures. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
GEN Edge speaks with ReCode Therapeutics CEO & President David J. Lockhart, PhD, to discuss how the company came together through a merger, and how it plans to harness lipid nanoparticles (LNPs) for genetic medicines.
Funds led by Carlyle have acquired a majority stake in Saama Technologies, according to a news release. The investment is valued at up to $430 million.
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!